Back9 Meters Biopharma Overview

9 Meters Biopharma Other Liabilities

Track 9 Meters Biopharma's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

9 Meters Biopharma Other Liabilities History

Loading

9 Meters Biopharma vs. peers: Other Liabilities Comparison

Loading

9 Meters Biopharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

9 Meters Biopharma (NMTR) FAQ

9 Meters Biopharma (NMTR) currently reports a other liabilities of $0 as of March 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore 9 Meters Biopharma's other liabilities history and peer comparisons.

9 Meters Biopharma's other liabilities changed from $0 to $0 (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

9 Meters Biopharma reported $0 in other liabilities as of March 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 9 Meters Biopharma, and consider following NMTR for alerts when major investors trade the stock.

9 Meters Biopharma is classified in the Technology sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NMTR with unrelated industries.